Clinical Trial Update: MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial [Phase 3]

View source ↗

Summary

This document describes a Phase 3 multicenter randomized trial comparing methotrexate versus tocilizumab for Giant Cell Arteritis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Giant Cell Arteritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING